However, Chiaserrini et al. reported that combined AUC of two biomarkers the FABP3 and Tau increased the accuracy of differential diagnosis in the dementia group (AD vs. Dementia with Levy body (DLB)) [31]. The gene discussed is MAPT; the disease is dementia.